UPDATED: BioZorb is FDA cleared for the radiographic marking of soft tissue sites for future procedures such as radiation therapy. 

Cancers of the prostate (17%), female breast (13%), and lung (12%) accounted for the largest share of the tally, experts noted. 

Rads only reported this incidental finding in about 31% to 44% of cases, experts detailed in the Journal of the American College of Radiology. 

"I am hoping that primary care physicians see that risks of screening are manageable, and the benefits are tremendous," said Dartmouth's Debra L. Monticciolo, MD. 

The dispute dates to August, when Suzanne Garraffa first contacted Connecticut-based Jefferson Radiology seeking X-rays. 

The Centers for Medicare & Medicaid Services started allowing this perk in 2020 amid the pandemic, but it is slated to go away by the end of 2024. 

“CT scan” was the third most-searched term among healthcare consumers, and “ultrasound” was No. 4, according to Fair Health. 

Patients with such impediments also are more likely to present to practices with late-stage disease, experts detailed in JAMA Network Open.